BioTwin
PrivateLast Round
Grant
Nov 17, 2023
Total Funding Raised
$2.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioTwin is a health technology company that develops AI-powered virtual human twin platforms for clinical decision support and personalized preventive medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Medical AI, Precision Medicine
Business Model
B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioTwin Comparables
Compare BioTwin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CIPRA.ai | 68% | |
| ExactCure | 61% | |
| Twin Health | 61% |
BioTwin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 17, 2023 | ||||
| VC Round | Nov 29, 2022 | ||||
| Pre Seed | Apr 8, 2021 |
BioTwin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CTS Santé | Pre Seed |
| National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 25, 208% of headcount.
- May 25, 2024
Grew 33% QoQ from 15 to 20 employees.
BioTwin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioTwin's valuation, stock price, and market status.
Is BioTwin a public or private company?
BioTwin is a private company.
What is the current stock price of BioTwin?
BioTwin is a private company, so its shares have no public market price. Caplight tracks BioTwin's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioTwin worth (valuation)?
Valuation information for BioTwin is not publicly available.
Can I buy BioTwin stock?
BioTwin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioTwin's last funding round?
BioTwin's most recent funding round was Grant on November 17, 2023.
Who are the main investors in BioTwin?
Key investors in BioTwin include CTS Santé.
Will BioTwin IPO soon?
No public IPO plans have been announced for BioTwin.
How can I track BioTwin secondary market activity?
Caplight tracks bids, offers, and trades in BioTwin's shares on secondary markets.